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(2012). Front. Behav. Neurosci. 6:75. doi:
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The lack of effective pharmacotherapies
to prevent relapse to drug taking empha-
sizes the importance of fully character-
izing the brain pathways responsible for
this behavior (Kalivas and McFarland,
2003). Recently, there have been attempts
to more fully understand the brain cir-
cuitry responsible for drug-seeking behav-
ior, beyond the well-characterized nodes
such as the prefrontal cortex (PFC),
nucleus accumbens (NAC), and ventral
tegmental area (VTA). In this respect,
the review of Martin-Fardon and Boutrel
(2012) is important and timely and should
serve to stimulate continued focus on
the paraventricular thalamus (PVT) in the
addiction field. Indeed, their review is an
appropriate addition to the recent arti-
cle “Emerging, re-emerging, and forgot-
ten areas of the reward-circuit” (McGinty
et al., 2011).
The first purpose of this commen-
tary is to reiterate this point, but to
perhaps go one step further. Thus, in
response to the authors’ first question
(i.e., whether the PVT should be consid-
ered part of the drug-seeking circuitry),
we argue that there is sufficient anatom-
ical and functional evidence to support
this suggestion. For example, the PVT
sends glutamatergic projections to the
NAC and PFC (Christie et al., 1987;
Bubser and Deutch, 1998; Vertes and
Hoover, 2008), and a large percentage of
these projections are branched, suggest-
ing that a single PVT neuron can influ-
ence these areas simultaneously (Otake
and Nakamura, 1998). PVT neurons also
project to medial, central, and basal nuclei
of the amygdala as well as the bed
nucleus of stria terminalis (Vertes and
Hoover, 2008). Importantly, glutamater-
gic efferents from the PVT are closely
apposed to dopamine fibers in the NAC
shell (Pinto et al., 2003) and stimula-
tion of the PVT produces an efflux of
dopamine in this brain region (Jones
et al., 1989; Parsons et al., 2007). Earlier,
lesion and Fos-mapping studies were the
first to implicate the PVT as a reward-
responsive site. For example, acute psy-
chostimulant administration was found to
activate the PVT (Deutch et al., 1998)
and lesions of the PVT block the condi-
tioned locomotor response to a cocaine-
paired environment (Young and Deutch,
1998). More recent studies have extended
these initial findings. Work by McNally’s
group, and ours, has demonstrated that
lesions or chemical inactivation of the
PVT suppresses drug-seeking behavior.
For example, Hamlin et al. (2009) showed
that lesions of the PVT prevent context-
induced reinstatement of alcohol-seeking
and Marchant et al. (2010) showed that
intra-PVT infusion of a κ-opioid recep-
tor agonist also inhibits this behavior. Our
group has also shown that inactivation of
the PVT using TTX or intra-PVT injec-
tions of the inhibitory peptide cocaine- and
amphetamine-regulated transcript (CART)
attenuates cocaine-primed reinstatement
(James et al., 2010). This role likely extends
to cue-induced cocaine-seeking, as the
magnitude of reinstatement behavior is
strongly correlated with Fos-activation in
the PVT (Dayas et al., 2008; James et al.,
2011a). Together, these data strongly sup-
port a functional role for the PVT in
drug-seeking, however, it will be impor-
tant for future studies to apply electro-
physiological or optogenetic techniques to
dissect the circuit-level changes involving
PVT efferents onto reward-relevant brain
regions (Cao et al., 2011). Designer recep-
tors exclusively activated by designer drugs
(DREADD) may also be useful in allowing
for selective activation/inactivation of the
PVT during reinstatement testing (Dong
et al., 2010).
The second question the authors’ raise
in their review is whether orexin (hypocre-
tin) input within the PVT modulates rein-
statement behavior. We agree with the
authors that there is strong anatomical
evidence implicating the PVT as a site
of integration for drug-related hypotha-
lamic signaling. However, the answer
to this question appears less straight-
forward than their more general ques-
tion regarding the PVT, and we believe
that this second issue requires further
study—a point acknowledged by Martin-
Fardon and Boutrel. The authors cite
recent data from their laboratory support-
ing a role for PVT orexin in reinstate-
ment behavior. PVT infusions of orexin-
A reinstated both extinguished cocaine-
and sweetened condensed milk-seeking
(SCM) behavior. Interestingly, moderate
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doses of orexin-A produced a stronger
reinstatement of cocaine-seeking than for
SCM, indicating drug-induced adaptation
to orexin receptor expression/function in
the PVT (Martin-Fardon et al., 2011).
We recently tested the effect of intra-
PVT administration of SB-334867, an
orexin receptor 1 antagonist, on cue-
induced cocaine-seeking. Given our pre-
vious demonstration that drug-cue sen-
sitive PVT neurons are closely apposed
by orexin terminals (Dayas et al., 2008),
it was surprising that microinjections of
SB-334867, at a dose also likely to block
orexin receptor 2, had no effect on cue-
induced reinstatement of cocaine-seeking
(James et al., 2011b). In contrast, intra-
VTA SB-334867 suppressed drug-seeking
behavior (James et al., 2011b), consis-
tent with studies showing that infusions
of orexin peptide into the VTA enhance
dopamine release in the NAC (Narita
et al., 2006; Espana et al., 2010) and rein-
state drug-seeking (Wang et al., 2009).
Interestingly, we found reduced PVT
Fos-expression after intra-VTA SB-334867
infusion, but increased Fos-protein in
the NAC shell (James et al., 2012).
Previous reports indicate that the NAC
shell can exert an inhibitory influence
over drug-seeking through its projec-
tions to the LH (Millan et al., 2010).
Thus, it is possible that intra-VTA SB-
334867 reduced PVT recruitment and
increased NAC shell inhibitory output
to the LH, resulting in attenuated drug-
seeking behavior.
How can these apparent contradictory
findings relating to orexin signaling in
the PVT be reconciled? One plausible
explanation is that infusion of orexin-A
into PVT may have engendered a stress-
like response that evoked drug-seeking.
Indeed, Martin-Fardon and Boutrel dis-
cuss recent evidence that orexin signaling
in this region is important in regulating
negative emotional states. For example, Li
and colleagues report that intra-PVT infu-
sion of TCSOX229, an orexin receptor-2
antagonist, attenuates the expression of
anxiety-like behaviors produced by prior
footshock stress (Li et al., 2010) as well
as conditioned place aversion produced
by precipitated morphine withdrawal (Li
et al., 2011). Further, Heydendael and
colleagues recently showed that in rats
exposed to daily swim stress, orexin-A
application increases the responsivity of
PVT cells, and intra-PVT infusions of
SB-334867 prior to daily swim stress
inhibit the ACTH secretion in response
to novel stress (Heydendael et al., 2011).
Thus, it is possible that the disparate
findings regarding orexin signaling in
PVT may reflect a preferential role for
orexin signaling in stress-induced rein-
statement. Future studies using more
sophisticated techniques may help resolve
this issue.
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